CINECA IRIS Institutional Research Information System

SALERNO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.270
AS - Asia 4.597
EU - Europa 3.830
SA - Sud America 567
AF - Africa 210
OC - Oceania 20
Totale 17.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.025
IT - Italia 1.469
SG - Singapore 1.380
CN - Cina 1.187
HK - Hong Kong 614
VN - Vietnam 581
SE - Svezia 567
BR - Brasile 455
DE - Germania 454
BG - Bulgaria 229
GB - Regno Unito 205
TR - Turchia 204
CA - Canada 183
FR - Francia 170
FI - Finlandia 166
JP - Giappone 149
AT - Austria 141
IN - India 124
RU - Federazione Russa 120
UA - Ucraina 111
KR - Corea 87
CI - Costa d'Avorio 55
BD - Bangladesh 41
CH - Svizzera 38
MX - Messico 37
IQ - Iraq 34
NG - Nigeria 34
PK - Pakistan 33
NL - Olanda 31
ZA - Sudafrica 31
AR - Argentina 28
ID - Indonesia 26
BE - Belgio 24
SN - Senegal 24
PL - Polonia 22
ES - Italia 21
VE - Venezuela 19
AU - Australia 17
EC - Ecuador 17
UZ - Uzbekistan 17
JO - Giordania 16
CO - Colombia 15
CZ - Repubblica Ceca 15
EG - Egitto 15
SA - Arabia Saudita 15
KE - Kenya 14
IE - Irlanda 10
MA - Marocco 10
MY - Malesia 10
PE - Perù 10
AZ - Azerbaigian 9
KZ - Kazakistan 9
CL - Cile 8
DZ - Algeria 8
TW - Taiwan 8
PH - Filippine 7
GR - Grecia 6
OM - Oman 6
PY - Paraguay 6
UY - Uruguay 6
IL - Israele 5
IR - Iran 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
HU - Ungheria 4
LT - Lituania 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KH - Cambogia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
GA - Gabon 2
HN - Honduras 2
ME - Montenegro 2
MK - Macedonia 2
MN - Mongolia 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
SO - Somalia 2
ZM - Zambia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
Totale 17.474
Salva come PNG Salva come JPEG
Città #
Ashburn 847
Singapore 796
Woodbridge 746
Ann Arbor 631
Houston 603
Hong Kong 588
San Jose 534
Serra 508
Santa Clara 469
Chandler 440
Fairfield 404
Dallas 341
Milan 285
Beijing 235
Sofia 228
Shanghai 227
New York 185
Seattle 181
Wilmington 173
Ho Chi Minh City 169
Jacksonville 142
Los Angeles 140
Izmir 138
Ottawa 133
Boardman 132
Cambridge 129
Council Bluffs 129
Hanoi 119
Hefei 119
Vienna 115
Princeton 111
Lawrence 97
Lauterbourg 94
Tokyo 87
Frankfurt am Main 86
Seoul 86
London 85
Nanjing 79
Medford 78
Pisa 59
Des Moines 57
Helsinki 57
Abidjan 55
Dong Ket 52
Istanbul 51
Munich 50
Dearborn 46
Rho 45
São Paulo 44
Redondo Beach 41
Rome 41
Buffalo 37
Columbus 33
Düsseldorf 33
Boulder 31
Lagos 31
Turku 30
Bremen 29
Da Nang 27
Bern 26
Jüchen 25
Pune 25
Brussels 24
Dakar 24
Florence 24
Kunming 23
Nanchang 23
Redwood City 23
San Diego 22
Baltimore 20
Changsha 20
The Dalles 20
Orem 19
San Francisco 19
Chicago 18
Fuzhou 18
Ogden 18
Belo Horizonte 17
Hebei 17
Johannesburg 17
Lucca 17
Nürnberg 17
Shenyang 17
Warsaw 17
Washington 17
Tashkent 16
Amman 14
Toronto 14
Aversa 13
Livorno 13
Jinan 12
Nuremberg 12
Phoenix 12
Stockholm 12
Atlanta 11
Baghdad 11
Chennai 11
Guangzhou 11
Jiaxing 11
Manchester 11
Totale 12.249
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 416
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 278
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 246
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 243
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 232
An update into the medicinal chemistry of translocator protein (TSPO) ligands 213
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 213
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 210
TSPO Radioligands for Neuroinflammation: An Overview 209
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 209
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 207
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 207
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 206
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 201
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 201
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 200
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 198
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 196
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 194
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 194
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 194
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 194
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 194
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 193
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 191
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 190
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 189
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 189
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 188
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 188
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 186
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 184
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity 184
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 183
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 181
FACILE SYNTHESIS OF 3-SUBSTITUTED[1,2,4]TRIAZINO[3,4-F]PURINE-4,6,8-TRIONE DERIVATIVES 179
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 178
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 177
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 177
Carbonic anhydrase activation profile of indole-based derivatives 174
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 171
Synthesis and antiproliferative evaluation of new aryl substituted Pyrido[3’,2’:5,6]thiopyrano[4,3-c]pyrazoles 171
Synthesis of novel 1,4-dihydropyrido[3’,2’:5,6]thiopyrano[4,3-c]-pyrazoles and 5H-pyrido[3’,2’:5,6]thiopyrano[4,3-d]pyrimidines as potential antiproliferative agents 170
Mitochondrial permeability transition induced by novel pyridothiopyranopyrimidine derivatives: Potential new antimitochondrial antitumour agents. 169
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 169
Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents 167
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 166
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 166
Spirohydantoin Derivatives of Thiopyrano[2,3-b]pyridin-4(4H)-one as Potent in Vitro and in Vivo Aldose Reductase Inhibitors 163
Derivati spiroidantoinici del Tiopirano[2,3-b]piridin-4(4H)-one quali potenti inibitori dell’aldoso reduttasi 160
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 159
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 159
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 159
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 158
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 156
Novel Aldose Reductase Acetic acid Inhibitors Bearing a Five Membered heterocyclic core 156
Novel Antitumoral Pyrazolopyrimidines Based on Inhibition of Protein Tyrosine Kinase 154
Targeting the Translocator Protein (18 kDa) in Cardiac Diseases: State of the Art and Future Opportunities 153
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 153
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry 153
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 149
"Synthesis of purinobenzodiazepine and purinobenzotriazocine derivatives, two new heterocyclic ring system" 148
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 147
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 146
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 144
New oxazole and 1,2,4-oxadiazole derivatives as selective ligands at the Translocator Protein (TSPO) 142
Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis 142
Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization 141
Design, Synthesis, and Biological Evaluation of 3-Arylindazole Acetic Acid Derivatives as Aldose Reductase Inhibitors 140
Synthesis and biological evaluation of Modified 2-Phenylindol-3-ylglyoxylamides as good candidates for the development of radioligands for the visualization of peripheral benzodiazepine receptor 139
Exploiting the pyrazolo[3,4-d]pyrimidinone ring system as a useful template for the obtainment of potent adenosine deaminase inhibitors 138
"Synthesis of pyridothiopyranoindole and of pyridothiopyranoquinoline derivatives as novel tetracyclic ring system" 137
Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy-An Overview 136
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 136
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies 135
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 135
Design, synthesis, and biological evaluation of novel fluorescent probes targeting the Translocator Protein (18 kDa) (TSPO) 134
Pyridopyrimidinone Derivatives as Novel Therapeutic Agents for the Topic Treatment of Vessel Walls Subjected to Percutaneous Intervention 131
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit a- and ß-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms 130
Novel Pyrazolopyrimidine Derivatives as Therapeutic Agents for the Treatment of Medullary Thyroid Carcinoma 129
SYNTHESIS OF NOVEL 5H,11H-PYRIDO[2',3':2,3]THIOPIRANO[4,3-B]-INDOLES BY FISCHER-INDOLE CYCLIZATION. 129
Targeting the Translocator protein (TSPO) with 2-phenylindol-3-ylglyoxylamide derivatives 128
High Affinity Central Benzodiazepine Receptor Ligands: Synthesis and Biological Evaluation of a Series of Phenyltriazolobenzotriazindione Derivatives (PTBTs) 127
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 127
NOVEL KINASE INHIBITORS IN THYROID CANCER TREATMENT: SYNTHESIS AND BIOLOGICAL EVALUATION 126
"Synthesis, DNA binding and in vitro antiproliferative activity of quinazobenzimidazole derivatives as potential antitumor agents". 126
Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents 124
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo[3,4-d]pyrimidine adenosine A(3) receptor antagonists. 123
Synthesis and Antiproliferative Activity of New Aminoalkyl Substituted Benzothiopyranoindoles 121
Substituted 2-Arylindolglyoxylamides as Potent Translocator Protein (18 kDa) TSPO ligands: Synthesis and Biological Evaluation 121
Indole-Based Compounds in the Development of Anti-Neurodegenerative Agents 118
"Sintesi e attività antiproliferativa di sistemi Pirido[3’,2’:5,6]tiopirano[4,3-c]pirazolici 2-aril sostituiti" 116
2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting 115
"Facile sintesi di nuove molecole polieterocicliche a partire dal 2-guanidinobenzimidazolo" 106
Synthesis and in vitro Antiproliferative Activity of New Substituted Benzo[3',2':5,6]thiopyrano[4,3-d]pyrimidines 106
Novel 3-Aryl-1,2,4triazino4,3-abenzimidazol-4(10H)-ones (ATBI) as selective A2A adenosine receptor antagonists 104
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 103
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo3,4-Dpyrimidine adenosine A3 receptor antagonists 102
Totale 16.796
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 0 0 129
2021/20221.155 40 95 53 69 178 150 37 51 41 37 57 347
2022/20231.631 198 281 115 147 202 202 18 114 263 6 64 21
2023/20241.347 144 134 150 92 161 275 102 49 12 22 88 118
2024/20253.650 30 124 44 230 428 412 253 179 332 457 386 775
2025/20264.622 254 475 459 325 474 357 992 218 359 417 185 107
Totale 17.764